share_log

和元生物(688238.SH)发布2023年度业绩，净亏损1.28亿元，同比由盈转亏

Heyuan Biotech (688238.SH) announced its 2023 annual results, with a net loss of 128 million yuan, changing from profit to loss over the previous year

Zhitong Finance ·  Apr 24 21:50

Heyuan Biotech (688238.SH) disclosed its 2023 annual report, and the company achieved revenue of 2 in 2023...

Zhitong Finance App News, Heyuan Biotech (688238.SH) disclosed the 2023 annual report. The company achieved revenue of 205 million yuan in 2023, a year-on-year decrease of 29.69%; net profit loss to mother of 128 million yuan, which changed from profit to loss over the previous year; after deducting loss of 134 million yuan in non-net profit, which changed from profit to loss over the previous year; basic earnings per share -0.199 yuan.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment